Socioeconomic status and event free survival in pediatric acute lymphoblastic leukemia: A population-based cohort study

Leukemia Research

Volumn 38, Issue 12, 2014, Pages 1407-1412

  Gupta, Sumit ^a   Sutradhar, Rinku ^b,c   Guttmann, Astrid ^a,b,d   Sung, Lillian ^a,d   Pole, Jason D ^e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e PEDIATRIC ONCOLOGY GROUP OF ONTARIO   (Canada)

Author keywords

Acute lymphoblastic leukemia; Cancer; Child; Disparities; Immigrant; Socioeconomic status

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANADA; CANCER PROGNOSIS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE SYSTEM; HUMAN; IMMIGRANT; INCOME; INFANT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RURAL AREA; SOCIAL STATUS; TERTIARY CARE CENTER; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; MORTALITY; MULTICENTER STUDY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; RURAL POPULATION; SOCIOECONOMICS; SURVIVAL RATE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; ONTARIO; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RURAL POPULATION; SOCIOECONOMIC FACTORS; SURVIVAL RATE; TERTIARY CARE CENTERS;

EID: 84915782603     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2014.08.017     Document Type: Article

References (43)

1. Canadian Cancer Society/National Cancer Institute of Canada Canadian Cancer Statistics 2008 2008, Canadian Cancer Society/National Cancer Institute of Canada, Toronto, Canada.
2. Pui C.H., Campana D., Pei D., Bowman W.P., Sandlund J.T., Kaste S.C., et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009, 360:2730-2741.
3. Locatelli F., Schrappe M., Bernardo M.E., Rutella S. How I treat relapsed childhood acute lymphoblastic leukemia. Blood 2012, 120:2807-2816.
4. Mullighan C.G., Downing J.R. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia 2009, 23:1209-1218.
5. Schmiegelow K., Forestier E., Kristinsson J., Soderhall S., Vettenranta K., Weinshilboum R., et al. Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Leukemia 2009, 23:557-564.
6. Booth C.M., Li G., Zhang-Salomons J., Mackillop W.J. The impact of socioeconomic status on stage of cancer at diagnosis and survival. Cancer 2010, 116:4160-4167.
7. Gage E. Examining the most relevant conceptualization of the socioeconomic construct for cancer research. Cancer Nurs 2010, 33:E1-E9.
8. Viana M.B., Fernandes R.A., de Carvalho R.I., Murao M. Low socioeconomic status is a strong independent predictor of relapse in childhood acute lymphoblastic leukaemia. Int J Cancer Suppl 1998, 11:56-61.
9. Gupta S., Antillon F.A., Bonilla M., Fu L., Howard S.C., Ribeiro R.C., et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer 2011, 117:4788-4795.
10. Kent E.E., Sender L.S., Largent J.A., Anton-Culver H. Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors. Cancer Causes Control 2009, 20:1409-1420.
11. Lightfoot T.J., Johnston W.T., Simpson J., Smith A.G., Ansell P., Crouch S., et al. Survival from childhood acute lymphoblastic leukaemia: the impact of social inequality in the United Kingdom. Eur J Cancer 2012, 48:263-269.
12. Bhatia S., Landier W., Shangguan M., Hageman L., Schaible A.N., Carter A.R., et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group. J Clin Oncol 2012, 30:2094-2101.
13. Hunger S.P., Lu X., Devidas M., Camitta B.M., Gaynon P.S., Winick N.J., et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol 2012, 30:1663-1669.
14. Gaynon P.S., Angiolillo A.L., Carroll W.L., Nachman J.B., Trigg M.E., Sather H.N., et al. Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia 2010, 24:285-297.
15. Silverman L.B., Stevenson K.E., O'Brien J.E., Asselin B.L., Barr R.D., Clavell L., et al. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia 2010, 24:320-334.
16. Salzer W.L., Devidas M., Carroll W.L., Winick N.J., Pullen J., Hunger S.P., et al. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group. Leukemia 2010, 24:355-370.
17. Greenberg M.L., Barr R.D., DiMonte B., McLaughlin E., Greenberg C. Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int J Cancer 2003, 105:88-91.
18. Inaba H., Greaves M., Mullighan C.G. Acute lymphoblastic leukaemia. Lancet Oncol 2013, 381:1943-1955.
19. Charalampopoulou A., Petridou E., Spyridopoulos T., Dessypris N., Oikonomou A., Athanasiadou-Piperopoulou F., et al. An integrated evaluation of socioeconomic and clinical factors in the survival from childhood acute lymphoblastic leukemia: a study in Greece. Eur J Cancer Prev 2004, 13:397-401.
20. Bonilla M., Gupta S., Vasquez R., Fuentes S.L., deReyes G., Ribeiro R.C., et al. Predictors of outcome and methodological issues in children with acute lymphoblastic leukaemia in El Salvador. Eur J Cancer 2010, 46:3280-3286.
21. Bhatia S. Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia. Curr Opin Pediatr 2004, 16:9-14.
22. Wilkins R. PCCF+ Version 4J. User's guide. Automated geographic coding based on the statistics Canada postal code conversion files. Including postal codes through September 2006 2007, Ottawa, Health Analysis and Measurement Group, Statistics Canada.
23. Statistics Canada Postal Code Conversion File (PCCF) Reference Guide 2008, Statistics Canada, Ottawa.
24. Kralj B. Measuring 'rurality' for purposes of health-care planning: an empirical measure for Ontario. Ont Med Rev 2000, (October).
25. Gupta S., Pole J.D., Guttmann A., Sung L. Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia. BMC Med Res Methodol 2013, 13.
26. Arico M., Schrappe M., Hunger S.P., Carroll W.L., Conter V., Galimberti S., et al. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol 2010, 28:4755-4761.
27. Heerema N.A., Nachman J.B., Sather H.N., Sensel M.G., Lee M.K., Hutchinson R., et al. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. Blood 1999, 94:4036-4045.
28. Braveman P.A., Cubbin C., Egerter S., Chideya S., Marehi K.S., Metzler M., et al. Socioeconomic status in health research: one size does not fit all. JAMA 2005, 294:2879-2888.
29. Galobardes B., Lynch J., Smith G.D. Measuring socioeconomic position in health research. Br Med Bull 2007, 81:21-37.
30. Fiscella K. Socioeconomic status disparities in healthcare outcomes: selection bias or biased treatment. Med Care 2004, 42:939-942.
31. James P.D., Wilkins R., Detsky A.S., Tugwell P., Manual D.G. Avoidable mortality by neighbourhood income in Canada: 25 years after the establishment of universal health insurance. J Epidemiol Community Health 2007, 61:287-296.
32. Birken C.S., Parkin P.C., To T., Wilkins R., Macarthur C. Neighborhood socioeonomic status and homicides among children in urban Canada. Pediatrics 2009, 123:e815-e819.
33. Ng E., Wilkins R., Fung M.F.K.F., Berthelot J.-M. Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996. CMAJ 2004, 170:1545-1549.
34. Woods L.M., Rachet B., Coleman M.P. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 2006, 17:5-19.
35. Hord M.H., Smith T.L., Culbert S.J., Frankel L.S., Pinkel D.P. Ethnicity and cure rates of Texas children with acute lymphoid leukemia. Cancer 1996, 77:563-569.
36. Petridou E., Dimitrova N., Eser S., Kachanov D., Karakilinc H., Varfolomeeva S., et al. Childhood leukemia and lymphoma: time trends and factors affective survival in five Southern and Eastern European cancer registries. Cancer Causes Control 2013, 24:1111-1118.
37. Gupta S., Wilejto M., Pole J.D., Guttmann A., Sung L. Low socioeconomic status is associated with worse survival in children with cancer: a systematic review. PLOS ONE 2014, 9:e89482.
38. Erdmann F., Kaatsch P., Zeeb H., Roman E., Lightfoot T., Schuz J. Survival from childhood acute lymphoblastic leukemia in West Germany: does socio-demographic background matter. Eur J Cancer 2014, 50:1345-1353.
39. Sergentanis T., Dessypris N., Kanavidis P., Skalkidis I., Baka M., Polychronopoulou S., et al. Socioeconomic status, area remoteness and survival from childhood leukemia: results from the Nationwide Registry for Childhood Hematological Malignancies in Greece. Eur J Cancer Prev 2013, 22:473-479.
40. Rondelli R., Dini G., De Rosa M., Quarello P., Bisogno G., Arico M., et al. Foreign children with cancer in Italy. Ital J Pediatr 2011, 37:1-9.
41. Gushulak B.D., Pottie K., Roberts J.H., Torres S., DesMeules M. Migration and health in Canada: health in the global village. CMAJ 2011, 183:E952-E958.
42. Cunningham S.A., Ruben J.D., Narayan K.M.V. Health of foreign-born people in the United States: a review. Health Place 2008, 14:623-635.
43. Harvey R.C., Mullighan C.G., Chen I.-M., Wharton W., Mikhail F.M., Carroll A., et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood 2010, 115:5312-5321.